EQS-News: DF Group enters blood plasma market
|
EQS-News: DF Deutsche Forfait AG
/ Key word(s): Takeover
Cologne, 30 April 2025 – The newly founded Deutsche Blutplasma HP GmbH, a wholly owned subsidiary of the intermediate holding company DF Health & Pharma Holding GmbH of DF Deutsche Forfait AG (ISIN: DE000A2AA204) (DF AG), signed a purchase agreement for the assets of the insolvent Ruhr-Plasma-Zentrum Bochum GmbH. DF Group is thus continuing its announced M&A strategy with targeted investments in the food and pharmaceutical sectors and is tapping into an extremely lucrative business segment by entering the field of blood plasma collection. Human blood plasma is needed in the pharmaceutical industry to produce various vital medicines such as blood coagulants and immunoglobulins. The global market for blood plasma derivatives is estimated to reach a volume of over 50 billion US dollars in 2024. According to the Federal Ministry of Health, around 15,000 blood and plasma donations are needed every day in Germany alone. A person in this country is allowed to donate plasma up to 60 times a year - in return for a legally permissible expense allowance. ‘The Ruhr-Plasma-Zentrum Bochum GmbH has developed into a permanent institution for plasma donors in Bochum over more than 30 years and is centrally located directly at the main railway station - Deutsche Blutsplasma HP GmbH would like to continue this success story,’ explains Management Board member Hans-Joachim von Wartenberg on the occasion of the completed asset deal. ‘The collection of blood plasma is fundamentally a very profitable business, and the company's operating business with a loyal base of stem donors has also developed positively in the past. We will now appoint a new management team that will systematically drive forward the expansion of business activities and, in particular, significantly strengthen marketing, which has been neglected to date.’ With this acquisition, DF Group has successfully completed its second M&A transaction within ten months. The new location in Bochum will serve as a starting point for the further expansion of the blood plasma division. It is conceivable that the company will open its own new stores as well as potentially taking over other locations throughout Germany or in neighbouring countries. The purchase will take effect on 1 May 2025 and is subject to the approval of the creditors' meeting. About DF Group DF Group is a finance company with the business units Foreign Trade Finance, Proprietary Trading and M&A. The industry focus is on the food, beverages, pharmaceutical and healthcare sectors. As a specialist in foreign trade financing with a regional focus on the Middle East, Europe and Central Asia, we offer our clients customised product solutions - based on many years of experience, a strong network and comprehensive compliance expertise. M&A activities have also been an integral part of DF Group's business model since 2024. Contact DF Deutsche Forfait AG Guido Janzen
30.04.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | DF Deutsche Forfait AG |
| Gustav-Heinemann-Ufer 56 | |
| 50968 Köln | |
| Germany | |
| Phone: | +49 221 97376 - 0 |
| E-mail: | dfag@dfag.de |
| Internet: | www.dfag.de |
| ISIN: | DE000A2AA204, DE000A1R1CC4, |
| WKN: | A2AA20, A1R1CC |
| Listed: | Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2126836 |
| End of News | EQS News Service |
|
|
2126836 30.04.2025 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | ||
| Sales1 | 12,43 | 8,89 | 9,95 | 11,10 | 29,54 | 10,46 | 10,60 | |
| EBITDA1,2 | 6,13 | 3,86 | 5,55 | 6,31 | 3,80 | 4,57 | 5,10 | |
| EBITDA-Margin3 | 49,32 | 43,42 | 55,78 | 56,85 | 12,86 | 43,69 | 48,11 | |
| EBIT1,4 | 5,96 | 3,69 | 5,34 | 6,09 | 3,59 | 4,19 | 4,60 | |
| EBIT-Margin5 | 47,95 | 41,51 | 53,67 | 54,87 | 12,15 | 40,06 | 43,40 | |
| Net Profit (Loss)1 | 3,25 | 6,81 | 6,76 | 5,40 | 1,66 | 1,88 | 2,20 | |
| Net-Margin6 | 26,15 | 76,60 | 67,94 | 48,65 | 5,62 | 17,97 | 20,76 | |
| Cashflow1,7 | 6,51 | 2,75 | -18,51 | 16,80 | 18,99 | -9,83 | 2,70 | |
| Earnings per share8 | 0,27 | 0,57 | 0,57 | 0,45 | 0,14 | 0,16 | 0,14 | |
| Dividend per share8 | 0,00 | 0,00 | 0,00 | 0,04 | 0,00 | 0,06 | 0,06 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: KPMC Audit
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| DF Deutsche Forfait | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A2AA20 | DE000A2AA204 | AG | 13,67 Mio € | 24.05.2007 | Kaufen | 9F28WX8C+32 |
| PE 2026e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 12,78 | 6,59 | 1,94 | 9,13 | 0,49 | -1,39 | 1,31 |
|
Dividend '2023 in € |
Dividend '2024 in € |
Dividend '2025e in € |
Div.-Yield '2025e in % |
| 0,00 | 0,06 | 0,06 | 5,22% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 29.08.2025 | - | 30.09.2025 | - | 30.04.2025 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| -16,42% | -24,39% | -22,82% | -22,30% | -98,47% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
